Angioprotektivnoe properties lowering drugs from the group of inhibitors of dipeptidyl peptidase-4
Diabetes mellitus (DM) is a major health problem in all developed countries. It contributes to the development of atherosclerosis and increases the risk of cardiovascular events so blood glucose level correction is essential to preventing these complications. The relatively new and promising class o...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2013-09-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/view/31376 |
_version_ | 1818326578518556672 |
---|---|
author | E V Oskola A T Shubina Iu A Karpov |
author_facet | E V Oskola A T Shubina Iu A Karpov |
author_sort | E V Oskola |
collection | DOAJ |
description | Diabetes mellitus (DM) is a major health problem in all developed countries. It contributes to the development of atherosclerosis and increases the risk of cardiovascular events so blood glucose level correction is essential to preventing these complications. The relatively new and promising class of anti-diabetic drugs is dipeptidyl peptidase-4 inhibitors. By improving carbohydrate metabolism, they have angioprotective effects, such as anti-inflammatory and anti-atherosclerotic ones, including atherosclerotic plaque stabilization, improve endothelial function, lower blood pressure, and reduce the severity of albuminuria, which may have clinical implications for the prevention of macrovascular complications of type 2 DM. |
first_indexed | 2024-12-13T12:02:36Z |
format | Article |
id | doaj.art-93b3f57c69874c48b99ccb84c2da0849 |
institution | Directory Open Access Journal |
issn | 0040-3660 2309-5342 |
language | Russian |
last_indexed | 2024-12-13T12:02:36Z |
publishDate | 2013-09-01 |
publisher | "Consilium Medicum" Publishing house |
record_format | Article |
series | Терапевтический архив |
spelling | doaj.art-93b3f57c69874c48b99ccb84c2da08492022-12-21T23:47:03Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422013-09-0185910711228392Angioprotektivnoe properties lowering drugs from the group of inhibitors of dipeptidyl peptidase-4E V OskolaA T ShubinaIu A KarpovDiabetes mellitus (DM) is a major health problem in all developed countries. It contributes to the development of atherosclerosis and increases the risk of cardiovascular events so blood glucose level correction is essential to preventing these complications. The relatively new and promising class of anti-diabetic drugs is dipeptidyl peptidase-4 inhibitors. By improving carbohydrate metabolism, they have angioprotective effects, such as anti-inflammatory and anti-atherosclerotic ones, including atherosclerotic plaque stabilization, improve endothelial function, lower blood pressure, and reduce the severity of albuminuria, which may have clinical implications for the prevention of macrovascular complications of type 2 DM.https://ter-arkhiv.ru/0040-3660/article/view/31376angioprotectiontype 2 diabetes mellitusdipeptidyl peptidase-4 inhibitorsincretins |
spellingShingle | E V Oskola A T Shubina Iu A Karpov Angioprotektivnoe properties lowering drugs from the group of inhibitors of dipeptidyl peptidase-4 Терапевтический архив angioprotection type 2 diabetes mellitus dipeptidyl peptidase-4 inhibitors incretins |
title | Angioprotektivnoe properties lowering drugs from the group of inhibitors of dipeptidyl peptidase-4 |
title_full | Angioprotektivnoe properties lowering drugs from the group of inhibitors of dipeptidyl peptidase-4 |
title_fullStr | Angioprotektivnoe properties lowering drugs from the group of inhibitors of dipeptidyl peptidase-4 |
title_full_unstemmed | Angioprotektivnoe properties lowering drugs from the group of inhibitors of dipeptidyl peptidase-4 |
title_short | Angioprotektivnoe properties lowering drugs from the group of inhibitors of dipeptidyl peptidase-4 |
title_sort | angioprotektivnoe properties lowering drugs from the group of inhibitors of dipeptidyl peptidase 4 |
topic | angioprotection type 2 diabetes mellitus dipeptidyl peptidase-4 inhibitors incretins |
url | https://ter-arkhiv.ru/0040-3660/article/view/31376 |
work_keys_str_mv | AT evoskola angioprotektivnoepropertiesloweringdrugsfromthegroupofinhibitorsofdipeptidylpeptidase4 AT atshubina angioprotektivnoepropertiesloweringdrugsfromthegroupofinhibitorsofdipeptidylpeptidase4 AT iuakarpov angioprotektivnoepropertiesloweringdrugsfromthegroupofinhibitorsofdipeptidylpeptidase4 |